• $21.5M
    Market Cap
  • -86.76%
    1-Year Change
  • Drug Manufacturers - General
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
-197,382
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
Gross Profit
-197,382
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
Research and Development Expense
-16.4M
+365.98%
-3.5M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
Total Operating Expenses
34.4M
+207.30%
11.2M
N/A
Operating Profit
-34.4M
+207.30%
-11.2M
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
-197,382
N/A
N/A
N/A
Interest Income and Expense and Net
-197,382
N/A
0
N/A
Total Nonoperating Income and Expense
-1.1M
-4,374.24%
25,386
N/A
Income before Taxes
-47.3M
+322.88%
-11.2M
N/A
Income Taxes
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-47.3M
+323.84%
-11.2M
N/A
Net Income from Continuing Operations Applicable to Common
-47.3M
+323.84%
-11.2M
N/A
Basic EPS and Net Income
-2.74
+136.21%
-1.16
N/A
Diluted EPS and Net Income
-2.74
+136.21%
-1.16
N/A
Basic Weighted Average Shares
17.3M
+79.68%
9.6M
N/A
Diluted Weighted Average Shares
17.3M
+79.68%
9.6M
N/A
Balance Sheet
Cash and Cash Equivalents
8.7M
+109.04%
4.2M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
8.7M
+109.04%
4.2M
N/A
Total Current Assets
9.9M
+83.90%
5.4M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
Total Assets
10.1M
+78.18%
5.6M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
5.2M
N/A
N/A
N/A
Total Current Liabilities
9.9M
+330.92%
2.3M
N/A
Total Long-Term Debt
25,865
N/A
N/A
N/A
Total Long-Term Liabilities
60,139
-70.80%
205,945
N/A
Total Liabilities
10.0M
+299.02%
2.5M
N/A
Retained Earnings
-64.3M
+122.63%
-28.9M
N/A
Total Stockholders Equity
-67,554
-102.16%
3.1M
N/A
Total Shares Outstanding
25.2M
+113.06%
11.8M
N/A
Cash Flow
Cash from Operating Activities
-22.8M
+122.27%
-10.2M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
-4.6M
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
31.9M
+151.65%
12.7M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
Operating Margin
17,407.52%
N/A
N/A
N/A
Return on Assets
-602.00%
N/A
N/A
N/A
Return on Equity
-3,083.09%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
Current Ratio
1.00
N/A
N/A
N/A
Cash Ratio
0.88
N/A
N/A
N/A
Debt-to-Equity Ratio
-78.03
N/A
N/A
N/A
Debt-to-Assets Ratio
0.52
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow